ACE2 and COVID-19: Since spike protein/ACE2 interactions are known to downregulate the ACE2 protein through multiple mechanisms [22,65] and we observed that the brains of COVID-19 patients show reduced ACE2 expression (Figure 3), we hypothesize that this amplification mechanism would be an efficient way for the virus to promote and worsen pathogenesis in various organs, including the brain.